ArriVent BioPharma, Inc. (AVBP)
NASDAQ: AVBP · Real-Time Price · USD
27.45
+0.86 (3.23%)
Nov 22, 2024, 4:00 PM EST - Market closed
ArriVent BioPharma Employees
ArriVent BioPharma had 40 employees as of December 31, 2023.
Employees
40
Change
n/a
Growth
n/a
Revenue / Employee
n/a
Profits / Employee
-$2,026,200
Market Cap
924.99M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2023 | 40 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Healthcare Services Group | 33,400 |
| Cytek Biosciences | 676 |
| Paragon 28 | 574 |
| Immatics | 535 |
| Zymeworks | 278 |
| Evolus | 273 |
| Liquidia | 145 |
| Nuvation Bio | 51 |
AVBP News
- 2 months ago - ArriVent Announces Positive Proof-Of-Concept Global Phase 1b Interim Data for Firmonertinib Monotherapy In First-Line EGFR PACC Mutant Non-Small Cell Lung Cancer At The 2024 World Conference On Lung Cancer - GlobeNewsWire
- 3 months ago - Aarvik Therapeutics Announces Option Exercise by Collaboration Partner ArriVent BioPharma - Business Wire
- 3 months ago - ArriVent BioPharma Reports Second Quarter 2024 Financial Results - GlobeNewsWire
- 3 months ago - ArriVent to Present Proof-Of-Concept Phase 1b Data for Firmonertinib in EGFR PACC Mutant Non-Small Cell Lung Cancer at the 2024 World Conference on Lung Cancer - GlobeNewsWire
- 6 months ago - ArriVent Announces a Multi-Target ADC Collaboration with Alphamab - GlobeNewsWire
- 6 months ago - ArriVent Appoints John Hohneker, M.D., to its Board of Directors - GlobeNewsWire
- 7 months ago - ArriVent BioPharma Reports First Quarter 2024 Financial Results - GlobeNewsWire
- 7 months ago - ArriVent Appoints Kristine Peterson to its Board of Directors - GlobeNewsWire